BSH 2016: Expert discussion on idelalisib
27 Apr 2016
BSH 2016: Expert discussion on idelalisib
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy
NY-ESO-1 immunotherapy for ovarian cancer
Normal and neoplastic stem cells
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers
Novel agents before and after stem cell transplantation for myeloma
EBMT 2016 Highlights: Expert discussion
Reprogramming the cancer microenvironment with vaccine-based therapy
Immunotherapy and personalised medicine in review
Rationale for combining immunotherapy with chemotherapy
Editor's Choice for March 2016